Cookies

Like most websites The Ophthalmologist uses cookies. In order to deliver a personalized, responsive service and to improve the site, we remember and store information about how you use it. Learn more.
Subspecialties Glaucoma

Finger on the Pulse

At a Glance

  • Micropulse transscleral cyclophotocoagulation (MP-TSCPC) has proven to be a safe, effective and reliable approach for lowering IOP
  • Unlike other interventions, MP-TSCPC delivers energy in a 31.3 percent duty cycle, allowing tissue to cool between each application, so there is minimal impact on target tissue and a reduced risk of injury to adjacent ocular tissue
  • MP-TSCPC can be used early in the disease course and requires minimal medication, reducing the reliance on anti-inflammatory drops post-procedure
  • It can also be used on a wide range of glaucoma severity, not just those in the most advanced stages of disease progression.

Read the full article now

Log in or register to read this article in full and gain access to The Ophthalmologist’s entire content archive. It’s FREE and always will be!

Login

Or register now - it’s free and always will be!

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine
Register

Or Login via Social Media

By clicking on any of the above social media links, you are agreeing to our Privacy Notice.

About the Author

Nir Shoham-Hazon

Nir Shoham-Hazon is an eye physician and surgeon, assistant professor in the Department of Ophthalmology and Visual Sciences, Dalhousie University in Halifax, Canada, and clinical assistant professor in the Faculty of Medicine, Memorial University of Newfoundland, Canada. Shoham-Hazon is in independent practice and is a staff Ophthalmologist at the Miramichi Regional Hospital in Miramichi, Canada.

Register to The Ophthalmologist

Register to access our FREE online portfolio, request the magazine in print and manage your preferences.

You will benefit from:

  • Unlimited access to ALL articles
  • News, interviews & opinions from leading industry experts
  • Receive print (and PDF) copies of The Ophthalmologist magazine

Register